Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 09:36 am Sale | 2024-09-30 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 0 0.000% | -2,900,000![]() (Position Closed) | Filing History |
2024-11-14 09:00 am Sale | 2024-09-30 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 1,882,654 3.780% | -2,121,577![]() (-52.98%) | Filing History |
2024-07-22 9:02 pm Purchase | 2024-07-12 | 13G | HilleVax, Inc. HLVX | TANG CAPITAL MANAGEMENT, LLC | 4,712,954 9.500% | 4,712,954![]() (New Position) | Filing History |
2024-05-31 2:00 pm Purchase | 2024-05-29 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 10,639,562 21.400% | 833,090![]() (+8.50%) | Filing History |
2024-02-14 6:46 pm Purchase | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Lightspeed Venture Partners Select IV L.P. | 2,313,432 4.800% | 400,000![]() (+20.90%) | Filing History |
2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | HilleVax, Inc. HLVX | RA Capital Management, L.P. | 0 0.000% | -1,760,019![]() (Position Closed) | Filing History |
2024-02-14 08:45 am Unchanged | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 2,900,000 5.990% | 0 (Unchanged) | Filing History |
2024-02-12 5:27 pm Purchase | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 4,004,231 8.270% | 1,310,130![]() (+48.63%) | Filing History |
2024-02-12 4:31 pm Unchanged | 2023-12-31 | 13G | HilleVax, Inc. HLVX | Carlyle Group Inc. CG | 1,838,486 3.800% | 0 (Unchanged) | Filing History |
2023-09-29 4:15 pm Purchase | 2023-09-20 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 2,900,000 6.140% | 2,900,000![]() (New Position) | Filing History |
2023-09-27 10:26 am Purchase | 2023-09-25 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% | 25,000![]() (+0.26%) | Filing History |
2023-05-05 4:12 pm Purchase | 2023-04-28 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% | 144,240![]() (+1.50%) | Filing History |
2023-02-14 4:45 pm Purchase | 2022-12-31 | 13G | HilleVax, Inc. HLVX | RA Capital Management, L.P. | 1,760,019 5.300% | 1,760,019![]() (New Position) | Filing History |
2023-02-10 4:16 pm Purchase | 2022-12-31 | 13G | HilleVax, Inc. HLVX | Carlyle Group Inc. CG | 1,838,486 5.500% | 1,838,486![]() (New Position) | Filing History |
2023-02-10 09:33 am Purchase | 2022-12-31 | 13G | HilleVax, Inc. HLVX | Deerfield Mgmt, L.P. | 2,694,101 8.080% | 76,153![]() (+2.91%) | Filing History |
2022-09-08 1:19 pm Purchase | 2022-09-06 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,637,232 28.800% | 513,660![]() (+5.63%) | Filing History |
2022-05-13 4:31 pm Purchase | 2022-05-03 | 13G | HilleVax, Inc. HLVX | Lightspeed Venture Partners Select IV L.P. | 1,913,432 5.700% | 1,913,432![]() (New Position) | Filing History |
2022-05-13 4:31 pm Purchase | 2022-05-03 | 13G | HilleVax, Inc. HLVX | Abingworth LLP | 1,838,486 5.500% | 1,838,486![]() (New Position) | Filing History |
2022-05-09 06:08 am Purchase | 2022-04-28 | 13D | HilleVax, Inc. HLVX | TAKEDA PHARMACEUTICAL CO LTD | 6,724,000 17.100% | 6,724,000![]() (New Position) | Filing History |
2022-05-06 4:15 pm Purchase | 2022-04-28 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 9,123,572 27.300% | 9,123,572![]() (New Position) | Filing History |